Oxazolidines from sugars: conformationally restricted derivatives of muramic acid.

[1]  H. Drobecq,et al.  Synthesis of conjugates between luteinizing hormone releasing hormone (LH-RH) and N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP) models of totally synthetic vaccines. , 2009, International journal of peptide and protein research.

[2]  A. Derome,et al.  Convenient syntheses of O-(2-acetamido-2-deoxy-β-d-glucopyranosyl)-(1→6 and 4)-N-acetylmuramoyl-l-alanyl-d-isoglutamine , 1989 .

[3]  B. Perly,et al.  Solution conformations of the immunomodulator muramyl peptides , 1988 .

[4]  P. Durette,et al.  Synthesis and immunoadjuvant activity of 2-acetamido-1,5-anhydro-2-deoxy-3-O-[(R)-2-propanoyl-l-alanyl-d-isoglutamine]-d-glucitol (“1-deoxymuramoyl dipeptide”) and its 6-(2-behenoyloxyisobutyrate)☆ , 1982 .

[5]  C. Dinarello,et al.  The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. , 1978, The Journal of infectious diseases.

[6]  E. Lederer,et al.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. , 1974, Biochemical and biophysical research communications.

[7]  T. H. Siddall,et al.  Nuclear magnetic resonance studies of amides , 1970 .

[8]  P. H. Gross,et al.  Optically pure N-substituted derivatives of benzyl 2-amino-2-deoxy-alpha-and -beta-D-glucopyranoside. , 1967, The Journal of organic chemistry.

[9]  J. Beloeil,et al.  On the 2,4-relative stereochemistry of N-substituted oxazolidines derived from phenylglycinol , 1990 .

[10]  J. Ježek,et al.  Muramyl-dipeptide analogues: Synthesis and biological activities , 1988 .